Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / articles / why is plant based medications focused abvc biopharm mwn benzinga

ABVC - Why Is Plant-Based Medications-Focused ABVC BioPharma Stock Trading Higher Today? | Benzinga

ABVC BioPharma Inc.

ABVC BioPharma Inc (NASDAQ: ABVC) and its subsidiary BioLite Inc received an aggregate of 46 million shares from AiBtl BioPharma Inc as its first milestone payment under a global licensing agreement. 

The agreement between the company and AiBtl placed a value of $460 ($10 per share) on such payment. 

The company entered into a definitive global licensing agreement with AiBtl in November 2023, for its CNS drugs with the indications of MDD (Major Depressive Disorder) and ADHD Full story available on Benzinga.com
Stock Information
Company Name: ABVC BioPharma Inc.
Stock Symbol: ABVC
Market: OTC
Website: abvcpharma.com
Menu
ABVC ABVC Quote ABVC Short ABVC News ABVC Articles ABVC Message Board
Get ABVC Alerts

News, Short Squeeze, Breakout and More Instantly...